![[Feedback]](/icons/banner/feedbackACT.gif){kind=icon}
![[For Subscribers]](/icons/banner/subscriberACT.gif){kind=icon}
![[Archive]](/icons/banner/archiveACT.gif){kind=icon}
![[Search]](/icons/banner/searchACT.gif){kind=icon}
![[Contents]](/icons/banner/tocACT.gif){kind=icon}
|
|
|
|
|
||
Vol. 287, Issue 2, 733-743, November 1998
Department of Pharmacology and Center for Molecular Neuroscience,
Vanderbilt University School of Medicine, Nashville, Tennessee (S.A.,
A.G., L.J.D., R.D.B.) and
Department of Anatomy and Cell Biology, Emory
University School of Medicine, Atlanta, Georgia (H.C.H.)
Using SK-N-SH cells, we observe that muscarinic acetylcholine receptor
activation by methacholine (MCh) rapidly and selectively diminishes
l-NE transport capacity (Vmax) with little or no change in
norepinephrine (NE) Km and without apparent
effects on membrane potential monitored directly under current clamp.
Over the same time frame, MCh exposure reduces the density of
[3H]nisoxetine binding sites (Bmax) in intact cells but
not in total membrane fractions, consistent with a loss of transport
capacity mediated by sequestration of transporters rather than changes in intrinsic transport activity or protein degradation. Similar changes
in NE transport and [3H]nisoxetine binding capacity are
observed after phorbol ester (
-PMA) treatment. Inhibition of PKC by
antagonists and downregulation of PKC by chronic treatment with phorbol
esters abolishes -PMA-mediated effects but produce only a partial
blockade of MCh-induced effects. Neither muscarinic acetylcholine
receptor nor PKC activation require extracellular Ca++ to
diminish NET activity. In contrast, treatment of cells with the
Ca++/ATPase antagonist, thapsigargin in
Ca++-free medium, eliminates the staurosporine-insensitive
component of MCh regulation. These findings were further corroborated
by the ability of
[1,2-bis(o-amino-phenoxy)ethane-N,N,N',N'-tetraacetic acid
tetra(acetoxymethyl)ester application in Ca++-free medium
to abolish NET regulation by MCh. Although they may contribute to basal
NET expression, we could not implicate CaMKII-, PKA- or nitric
oxide-linked pathways in MCh regulation. Together, these findings
1) provide evidence in support of G-protein coupled receptor-mediated regulation of catecholamine transport, 2) reveal intracellular Ca++-sensitive, PKC-dependent and
-independent pathways that serve to regulate NET expression and 3)
indicate that the diminished capacity for NE transport evident after
mAChR and PKC activation involves a redistribution of NET protein.
This article has been cited by other articles:
|
|
 |
|
  M. S. Mazei-Robison, E. Bowton, M. Holy, M. Schmudermaier, M. Freissmuth, H. H. Sitte, A. Galli, and R. D. Blakely Anomalous Dopamine Release Associated with a Human Dopamine Transporter Coding Variant J. Neurosci., July 9, 2008; 28(28): 7040 - 7046. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. A. Paczkowski, I. A. Sharpe, S. Dutertre, and R. J. Lewis {chi}-Conotoxin and Tricyclic Antidepressant Interactions at the Norepinephrine Transporter Define a New Transporter Model J. Biol. Chem., June 15, 2007; 282(24): 17837 - 17844. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Wei, J. M. Williams, C. Dipace, U. Sung, J. A. Javitch, A. Galli, and C. Saunders Dopamine Transporter Activity Mediates Amphetamine-Induced Inhibition of Akt through a Ca2+/Calmodulin-Dependent Kinase II-Dependent Mechanism Mol. Pharmacol., March 1, 2007; 71(3): 835 - 842. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Dipace, U. Sung, F. Binda, R. D. Blakely, and A. Galli Amphetamine Induces a Calcium/Calmodulin-Dependent Protein Kinase II-Dependent Reduction in Norepinephrine Transporter Surface Expression Linked to Changes in Syntaxin 1A/Transporter Complexes Mol. Pharmacol., January 1, 2007; 71(1): 230 - 239. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. D. Jayanthi, B. Annamalai, D. J. Samuvel, U. Gether, and S. Ramamoorthy Phosphorylation of the Norepinephrine Transporter at Threonine 258 and Serine 259 Is Linked to Protein Kinase C-mediated Transporter Internalization J. Biol. Chem., August 18, 2006; 281(33): 23326 - 23340. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. M. Kreusser, M. Haass, S. J. Buss, S. E. Hardt, S. H. Gerber, R. Kinscherf, H. A. Katus, and J. Backs Injection of Nerve Growth Factor Into Stellate Ganglia Improves Norepinephrine Reuptake Into Failing Hearts Hypertension, February 1, 2006; 47(2): 209 - 215. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. D. Blakely, L. J. DeFelice, and A. Galli Biogenic Amine Neurotransmitter Transporters: Just When You Thought You Knew Them Physiology, August 1, 2005; 20(4): 225 - 231. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. A. Vaughan Phosphorylation and Regulation of Psychostimulant-Sensitive Neurotransmitter Transporters J. Pharmacol. Exp. Ther., July 1, 2004; 310(1): 1 - 7. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. D. Jayanthi, D. J. Samuvel, and S. Ramamoorthy Regulated Internalization and Phosphorylation of the Native Norepinephrine Transporter in Response to Phorbol Esters: EVIDENCE FOR LOCALIZATION IN LIPID RAFTS AND LIPID RAFT-MEDIATED INTERNALIZATION J. Biol. Chem., April 30, 2004; 279(18): 19315 - 19326. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. K. Hahn, D. Robertson, and R. D. Blakely A Mutation in the Human Norepinephrine Transporter Gene (SLC6A2) Associated with Orthostatic Intolerance Disrupts Surface Expression of Mutant and Wild-Type Transporters J. Neurosci., June 1, 2003; 23(11): 4470 - 4478. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T.-A. Ansah, S. Ramamoorthy, S. Montanez, L. C. Daws, and R. D. Blakely Calcium-Dependent Inhibition of Synaptosomal Serotonin Transport by the {alpha}2-Adrenoceptor Agonist 5-Bromo-N-[4,5-dihydro-1H-imidazol-2-yl]-6-quinoxalinamine (UK14304) J. Pharmacol. Exp. Ther., June 1, 2003; 305(3): 956 - 965. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
U. Sung, S. Apparsundaram, A. Galli, K. M. Kahlig, V. Savchenko, S. Schroeter, M. W. Quick, and R. D. Blakely A Regulated Interaction of Syntaxin 1A with the Antidepressant-Sensitive Norepinephrine Transporter Establishes Catecholamine Clearance Capacity J. Neurosci., March 1, 2003; 23(5): 1697 - 1709. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Granas, J. Ferrer, C. J. Loland, J. A. Javitch, and U. Gether N-terminal Truncation of the Dopamine Transporter Abolishes Phorbol Ester- and Substance P Receptor-stimulated Phosphorylation without Impairing Transporter Internalization J. Biol. Chem., February 7, 2003; 278(7): 4990 - 5000. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. E. Torres, A. Carneiro, K. Seamans, C. Fiorentini, A. Sweeney, W.-D. Yao, and M. G. Caron Oligomerization and Trafficking of the Human Dopamine Transporter. MUTATIONAL ANALYSIS IDENTIFIES CRITICAL DOMAINS IMPORTANT FOR THE FUNCTIONAL EXPRESSION OF THE TRANSPORTER J. Biol. Chem., January 17, 2003; 278(4): 2731 - 2739. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. D. Foster, B. Pananusorn, and R. A. Vaughan Dopamine Transporters Are Phosphorylated on N-terminal Serines in Rat Striatum J. Biol. Chem., July 5, 2002; 277(28): 25178 - 25186. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. E. Derbez, R. M. Mody, and L. L. Werling sigma 2-Receptor Regulation of Dopamine Transporter via Activation of Protein Kinase C J. Pharmacol. Exp. Ther., April 1, 2002; 301(1): 306 - 314. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Apparsundaram, U. Sung, R. D. Price, and R. D. Blakely Trafficking-Dependent and -Independent Pathways of Neurotransmitter Transporter Regulation Differentially Involving p38 Mitogen-Activated Protein Kinase Revealed in Studies of Insulin Modulation of Norepinephrine Transport in SK-N-SH Cells J. Pharmacol. Exp. Ther., November 1, 2001; 299(2): 666 - 677. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Roubert, C. Sagne, M. Kapsimali, P. Vernier, F. Bourrat, and B. Giros A Na+/Cl--Dependent Transporter for Catecholamines, Identified as a Norepinephrine Transporter, Is Expressed in the Brain of the Teleost Fish Medaka (Oryzias latipes) Mol. Pharmacol., September 1, 2001; 60(3): 462 - 473. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. D. Mayfield and N. R. Zahniser Dopamine D2 Receptor Regulation of the Dopamine Transporter Expressed in Xenopus laevis Oocytes Is Voltage-Independent Mol. Pharmacol., January 1, 2001; 59(1): 113 - 121. [Abstract] [Full Text]
|
|
|
|
|
|
A. L. Bauman, S. Apparsundaram, S. Ramamoorthy, B. E. Wadzinski, R. A. Vaughan, and R. D. Blakely Cocaine and Antidepressant-Sensitive Biogenic Amine Transporters Exist in Regulated Complexes with Protein Phosphatase 2A J. Neurosci., October 15, 2000; 20(20): 7571 - 7578. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. R. Shannon, N. L. Flattem, J. Jordan, G. Jacob, B. K. Black, I. Biaggioni, R. D. Blakely, and D. Robertson Orthostatic Intolerance and Tachycardia Associated with Norepinephrine-Transporter Deficiency N. Engl. J. Med., February 24, 2000; 342(8): 541 - 549. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. M. Daniels and S. G. Amara Regulated Trafficking of the Human Dopamine Transporter. CLATHRIN-MEDIATED INTERNALIZATION AND LYSOSOMAL DEGRADATION IN RESPONSE TO PHORBOL ESTERS J. Biol. Chem., December 10, 1999; 274(50): 35794 - 35801. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. E. Melikian and K. M. Buckley Membrane Trafficking Regulates the Activity of the Human Dopamine Transporter J. Neurosci., September 15, 1999; 19(18): 7699 - 7710. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Saunders, J. V. Ferrer, L. Shi, J. Chen, G. Merrill, M. E. Lamb, L. M. F. Leeb-Lundberg, L. Carvelli, J. A. Javitch, and A. Galli Amphetamine-induced loss of human dopamine transporter activity: An internalization-dependent and cocaine-sensitive mechanism PNAS, June 6, 2000; 97(12): 6850 - 6855. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. L. Beckman, E. M. Bernstein, and M. W. Quick Multiple G Protein-Coupled Receptors Initiate Protein Kinase C Redistribution of GABA Transporters in Hippocampal Neurons J. Neurosci., June 1, 1999; 19(11): RC9 - RC9. [Abstract] [Full Text] [PDF]
|
|
 |
 |
 |
|
 |
 |
 |
